Bailong Chuangyuan(SH:605016) Xin Lang Cai Jing·2026-02-11 07:39Core Viewpoint - The company is establishing a wholly-owned subsidiary, Bailong Chuangyuan (Nanjing) Biotechnology Co., Ltd., with an investment of 10 million RMB to enhance its international trade capabilities and improve overall profitability [1] Group 1: Company Strategy - The establishment of the Nanjing subsidiary aligns with the company's strategic development plan and operational needs [1] - The company will focus on recruiting international trade talent to leverage Nanjing's geographical advantages [1] Group 2: Business Development - The new subsidiary aims to expand overseas customer development and technical exchanges [1] - This initiative is expected to increase the company's export revenue and enhance its service capabilities for overseas clients [1]